CirChem AB
STO:CIRCHE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
CirChem AB
STO:CIRCHE
|
SE |
Balance Sheet
Balance Sheet Decomposition
CirChem AB
CirChem AB
Balance Sheet
CirChem AB
| Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & Cash Equivalents |
1
|
1
|
2
|
22
|
15
|
10
|
17
|
12
|
14
|
|
| Cash |
1
|
1
|
2
|
22
|
15
|
10
|
17
|
12
|
14
|
|
| Total Receivables |
0
|
3
|
13
|
1
|
1
|
1
|
2
|
2
|
2
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
2
|
|
| Other Receivables |
0
|
3
|
13
|
1
|
1
|
1
|
0
|
0
|
1
|
|
| Inventory |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Total Current Assets |
1
|
4
|
15
|
24
|
16
|
11
|
19
|
14
|
17
|
|
| PP&E Net |
7
|
17
|
30
|
33
|
36
|
40
|
40
|
47
|
52
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
8
N/A
|
22
+160%
|
45
+106%
|
57
+28%
|
52
-9%
|
50
-4%
|
59
+18%
|
61
+4%
|
69
+14%
|
|
| Liabilities | ||||||||||
| Accounts Payable |
1
|
4
|
3
|
3
|
2
|
2
|
1
|
2
|
1
|
|
| Accrued Liabilities |
0
|
2
|
0
|
1
|
2
|
4
|
2
|
2
|
2
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
1
|
2
|
2
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
2
|
18
|
17
|
12
|
6
|
9
|
|
| Total Current Liabilities |
1
|
6
|
5
|
8
|
23
|
23
|
15
|
10
|
12
|
|
| Long-Term Debt |
3
|
7
|
7
|
5
|
3
|
2
|
9
|
5
|
13
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
3
N/A
|
13
+291%
|
12
-10%
|
12
+3%
|
26
+107%
|
25
-2%
|
24
-5%
|
15
-35%
|
25
+62%
|
|
| Equity | ||||||||||
| Common Stock |
0
|
0
|
0
|
1
|
1
|
1
|
2
|
2
|
3
|
|
| Retained Earnings |
5
|
4
|
5
|
4
|
18
|
23
|
17
|
1
|
12
|
|
| Additional Paid In Capital |
0
|
4
|
27
|
48
|
44
|
47
|
50
|
45
|
54
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
5
N/A
|
8
+68%
|
33
+294%
|
45
+37%
|
26
-41%
|
25
-5%
|
35
+40%
|
46
+30%
|
44
-3%
|
|
| Total Liabilities & Equity |
8
N/A
|
22
+160%
|
45
+106%
|
57
+28%
|
52
-9%
|
50
-4%
|
59
+18%
|
61
+4%
|
69
+14%
|
|
| Shares Outstanding | ||||||||||
| Common Shares Outstanding |
13
|
13
|
13
|
15
|
15
|
19
|
29
|
31
|
40
|
|